The OIG identified $178 million in combined MA overpayments received by Humana and UnitedHealthcare, as a federal watchdog formally accused both of upcoding. The consequence landed on the distribution side simultaneously: GoHealth shut down the majority of its operations and cut 103 jobs as the Trump administration weighs suspending new MA agent enrollment entirely.
Appeal overturn rates range 16%–93% by insurer
A study found that appealed prior authorization denials are often overturned, with reversal rates ranging from 16% to 93% depending on the insurer.
2027 plans adding PA to long-standing drug prescriptions
2027 MA plan formularies show insurers adding prior authorization requirements to drugs members have taken for years.
Optum Rx automates 64% of PA approvals in under 30 seconds
Optum Rx's PreCheck Prior Authorization tool automates 64% of approvals in under 30 seconds, getting patients onto therapy four days faster, according to a company executive.
CVS Aetna bundles cancer prior authorizations upfront
Aetna is bundling preapprovals for all cancer care types into one upfront request to reduce paperwork for physicians.
Federal watchdog accuses Humana, UnitedHealthcare of upcoding
A federal watchdog publicly accused Humana and UnitedHealthcare Medicare Advantage plans of upcoding.
Federal bill targets MA clawbacks
A new federal bill was introduced targeting Medicare Advantage clawbacks of overpayments.
OIG urges crackdown on equipment suppliers in MA
The OIG urged a crackdown on equipment suppliers in Medicare Advantage, citing payment accuracy concerns.
OIG finds $178M in combined MA overpayments
The OIG identified $178 million in combined Medicare Advantage overpayments received by Humana and UnitedHealthcare.
⊕ +1 from PriorAuth
CMS drops appeals timing and disenrollment measures from Star ratings
CMS decided to remove appeals timing and members-lost measures from Medicare Advantage Star ratings calculations.
Half of 2027 Star thresholds harder to reach
Half of Medicare Advantage Star ratings thresholds will be harder to achieve in 2027, raising the bar for plans seeking to maintain or improve ratings.
Trump administration may suspend new health insurance agent enrollment
The Trump administration is considering suspending enrollment of new private health insurance agents.
GoHealth shuts majority of operations, cuts 103 jobs
GoHealth announced it will shut down the majority of its operations and eliminate 103 positions.
Risk adjustment is a cost of participation, not a source of advantage.
Overturned by: any carrier attributing a margin beat to coding or risk-score improvement under V28, in two consecutive quarters
Watching: Watch whether CMS or OIG issues formal repayment demands — or the clawback bill advances to a committee vote — by end of Q4 2026 by December 31, 2026
Last call: ● TESTING
Prior authorisation moves from payer discretion to regulated process.
Overturned by: twelve months with no federal rule advancing and penalties staying nominal and unnamed
Watching: Watch whether CMS publishes 2027 MA formulary data showing net PA code count rising or falling market-wide, by November 2026 bid deadline disclosures by November 30, 2026
Last call: ● TESTING
Star ratings will be restructured, not merely disputed.
Overturned by: a full cycle published, unchallenged, with stable cut points
Watching: Watch whether the dropped appeals measures shift net QBP bonus dollars materially when 2027 Star ratings publish — a plan-level revenue swing of >1% would confirm the recalibration is consequential by October 2026 Star ratings release
Last call: ● TESTING
The independent distribution channel consolidates under financial stress.
Overturned by: a new entrant scaling profitably, or the channel carrying an AEP without a named intermediary failing
Watching: Watch whether the Trump administration formally suspends new agent enrollment before October 15 AEP start — if enacted, carrier enrollment through independent brokers will decline measurably in AEP 2026 by October 15, 2026
Last call: ● TESTING
Margin discipline is structural and permanent, not a cycle to wait out.
Overturned by: realised MA enrolment growing at or above market for the carriers who announced contraction, through two consecutive AEPs
Penetration keeps rising. Who captures the growth is unresolved.
The cost of margin recovery is passed through. Where it lands is unresolved.
Overturned by: margin recovery achieved through genuine cost reduction rather than transfer
Nothing has borne on this claim for 6 editions. It is not settled, it is unexamined.